Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 250 Show results per page	View Search Criteria \| Help With Results

Last Modified: 1/18/2008 First Published: 12/22/2005


1.		Phase IV Study of the Relationship Between Residual Platinum Levels in the Blood and Persistent Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care, Treatment				Active				18 and over				Other, Pharmaceutical / Industry				GERCOR-TAUROX SANOFI-GERCOR-TAUROX, EU-20573, NCT00274885

First Published: 11/14/2007


2.		Phase IV Study of Chemoresistance Markers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Biomarker/Laboratory analysis, Treatment				Active				18 and over				Other				CHUL-BIO-COLON RECF0356, INCA-RECF0356, NCT00559676


3.		OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				18 and over				Pharmaceutical / Industry				ML21380 NCT00577031

Last Modified: 6/15/2007 First Published: 5/23/2005


4.		Phase II/III Randomized Study of Oxaliplatin, Irinotecan, Leucovorin Calcium, and Fluorouracil Versus Gemcitabine as First-Line Chemotherapy in Patients With Metastatic Adenocarcinoma of the Pancreas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 to 75				Other				FRE-FNCLCC-ACCORD-11/0402 EU-20512, NCT00112658

Last Modified: 2/15/2007 First Published: 3/13/2006


5.		Phase II/III Randomized Study of Fluorouracil, Cisplatin, and Radiotherapy Versus Gemcitabine Hydrochloride and Oxaliplatin in Patients With Unresectable, Nonmetastatic Cancer of the Biliary Tract

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and over				Other, Pharmaceutical / Industry				FFCD-9902 SANOFI-FFCD-9902, LILLY-FFCD-9902, FFCD-FNCLCC-SFRO-9902, NCT00304135


6.		First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				D8480C00013 Eudract Number 2005-003440-66, NCT00384176


7.		FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				STX0206 NCT00724503


8.		FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				STX0207 NCT00735241

Last Modified: 1/13/2009 First Published: 3/24/2003


9.		Phase III Randomized Study of Preoperative Chemoradiotherapy Comprising Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin in Patients With Resectable Rectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				NSABP-R-04 NCT00058474, CALGB-NSABP-R-04

Last Modified: 8/3/2007 First Published: 9/24/2003


10.		Phase III Randomized Study of Leucovorin Calcium and Fluorouracil With or Without Oxaliplatin Versus Capecitabine With or Without Oxaliplatin in Patients With Metastatic Colorectal Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				Not specified				Other				NCRI-FOCUS2 MRC-CR09, EU-20303, NCT00070213

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute